A Study to Evaluate Efficacy and Safety of Vatiquinone for Treating Mitochondrial Disease in Participants With Refractory Epilepsy

Clinical trial NCT04378075 · TERMINATED

Trial details

NCT number: NCT04378075
Sponsor: PTC Therapeutics
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Mitochondrial Diseases Drug Resistant Epilepsy Leigh Disease Leigh Syndrome Mitochondrial Encephalopathy (MELAS)Pontocerebellar Hypoplasia Type 6 (PCH6)Alpers Disease Alpers Syndrome

Start date: 2020-09-28
Primary completion: 2023-03-18
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.